Ayyar D Ram, Sharma Khema R
Department of Neurology, University of Miami School of Medicine, 1150 NW 14th Street, Suite # 603, Miami, FL 33136, USA.
Curr Diab Rep. 2004 Dec;4(6):409-12. doi: 10.1007/s11892-004-0048-y.
There is a higher incidence of demyelinating peripheral neuropathy responsive to immunomodulating treatment in patients with diabetes mellitus. The diagnosis is often overlooked and the patients are given the label of "diabetic neuropathy." Progressive symmetric or asymmetric motor deficit, progressive sensory neuropathy in spite of optimal diabetic control, and unusually high cerebrospinal fluid protein level in "diabetic neuropathy" should alert the clinician to the possibility of an underlying treatable demyelinating peripheral neuropathy masquerading as "diabetic neuropathy."
糖尿病患者中对免疫调节治疗有反应的脱髓鞘性周围神经病发病率较高。该诊断常常被忽视，患者被贴上“糖尿病性神经病变”的标签。进行性对称性或不对称性运动功能缺损、尽管糖尿病控制良好仍出现进行性感觉神经病变，以及“糖尿病性神经病变”患者脑脊液蛋白水平异常升高，这些情况应提醒临床医生注意可能存在一种潜在可治疗的脱髓鞘性周围神经病，它伪装成了“糖尿病性神经病变”。
